MedTrace Logo

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

NCT04076696 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2022-08-08

Study results available
· View outcomes & findings →

Summary

This is a study that will evaluate the utility of a scatter reduction technique in reducing dose and increasing the sensitivity of stationary digital chest tomosynthesis (s-DCT) in the detection of lung lesions.

Conditions

  • Pulmonary Nodule, Solitary
  • Pulmonary Nodule, Multiple

Interventions

DEVICE

Scatter corrected s-DCT

All patients will have a breath held s-DCT scan in an anterior-posterior direction

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Ertan Pamuklar, MD · UNC Hospitals

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-26
Primary Completion
2021-08-26
Completion
2021-08-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04076696 on ClinicalTrials.gov